Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Chlumec Nad Cidlinou

14 clinical trials in Chlumec Nad Cidlinou, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Chlumec Nad Cidlinou at a glance
14
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

14 trials in Chlumec Nad Cidlinou

Open in trial search
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ferric Derisomaltose
  • Sponsor:Pharmacosmos A/S
Countries:CzechiaCzechia
  • Participants:18–64 years
  • Sponsor:Novo Nordisk A/S
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:Eli Lilly & Co.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB

Arteriosclerosis

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Chlumec Nad Cidlinou

What the registry says about research in the country

01 Cardiovascular Prevention Studies

Research focusing on primary prevention of atherosclerotic cardiovascular disease and innovative approaches to prevent heart failure development in high-risk patients.

  • Heart Failure Prevention
  • Cardiovascular Risk Management
  • Preventive Cardiology

These trials aim to evaluate new therapeutic combinations for reducing cardiovascular events in at-risk populations.

02 Lipid Management Research

Investigations into advanced treatments for hypercholesterolemia and innovative therapies targeting lipoprotein management in cardiovascular disease patients.

  • Cholesterol Reduction
  • Lipid-Lowering Therapies
  • Cardiovascular Biomarkers

Studies focus on evaluating novel approaches to achieve optimal lipid levels and improve patient outcomes.

03 Heart Failure Management

Clinical research examining treatments for acute decompensated heart failure and strategies to reduce cardiovascular mortality in patients with established heart conditions.

  • Acute Heart Failure
  • Cardiovascular Mortality
  • Treatment Optimization

These investigations aim to enhance therapeutic options for patients with various forms of heart failure.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.